| Literature DB >> 35192406 |
Joyce V B Borba1,2, Vinicius M Alves1, Rodolpho C Braga3, Daniel R Korn1, Kirsten Overdahl4, Arthur C Silva2, Steven U S Hall2, Erik Overdahl1, Nicole Kleinstreuer5, Judy Strickland6, David Allen6, Carolina Horta Andrade2, Eugene N Muratov1,7, Alexander Tropsha1.
Abstract
BACKGROUND: Modern chemical toxicology is facing a growing need to Reduce, Refine, and Replace animal tests (Russell 1959) for hazard identification. The most common type of animal assays for acute toxicity assessment of chemicals used as pesticides, pharmaceuticals, or in cosmetic products is known as a "6-pack" battery of tests, including three topical (skin sensitization, skin irritation and corrosion, and eye irritation and corrosion) and three systemic (acute oral toxicity, acute inhalation toxicity, and acute dermal toxicity) end points.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35192406 PMCID: PMC8863177 DOI: 10.1289/EHP9341
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 11.035
Computational software covering 6-pack end points.
| Software name | Endpoints | Computational approach | License | Access |
|---|---|---|---|---|
| Danish QSAR database | Acute oral, skin irritation and skin sensitization | Consensus model from ACDLabs, Leadscope, CASE Ultra, and SciQSAR | Free |
|
| T.E.S.T. | Acute oral | QSAR | Free |
|
| TOPKAT | Acute oral, Acute inhalation, eye irritation, skin irritation, and skin sensitization | QSAR | Commercial |
|
| ACD/Percepta | Acute oral, eye irritation, and skin irritation | QSAR | Commercial |
|
| CASE Ultra | Acute oral, acute inhalation, eye irritation, skin irritation, and skin sensitization | Structural alerts | Commercial |
|
| ToxTree | Eye irritation, skin irritation, and skin sensitization | Structural alerts | Free |
|
| Derek Nexus | Irritation, skin sensitization | Structural alerts | Commercial |
|
| OECD QSAR Toolbox | Eye irritation, skin irritation, and skin sensitization | QSAR and read-across | Free |
|
| VEGA | Skin sensitization | Read-across | Free |
|
| CATMoS (OPERA) | Acute Oral | Consensus model | Free |
|
| PredSkin (version 3.0) | Skin sensitization | QSAR | Free |
|
| REACHAcross (RASAR) | All 6-pack | Read-across and QSAR | Commercial |
|
Note: OECD, Organisation for Economic Co-operation and Development; QSAR, quantitative structure–activity relationship; RASAR, read-across structure–activity relationships.
Figure 1.General workflow of STopTox. Experimental data from all 6-pack end points were collected and carefully curated following a well-stablished protocol accepted by the cheminformatics community. The data were then integrated and QSAR models were built for each end point individually. Finally, the models were implemented in a publicly available web application termed STopTox available at https://stoptox.mml.unc.edu/.
Figure 2.Summary of data curation steps. Data sources: ECHA (ECHA 2019; ECHA and OECD 2019), Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM 2013), ToxValDB (Judson 2018), and National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM; ICCVAM 2019).
Statistical characteristics of QSAR models for 6-pack end points evaluated by 5-fold external cross-validation.
| End point | CCR | Se | Sp | PPV | NPV | Coverage | Number of compounds |
|---|---|---|---|---|---|---|---|
| Skin sensitization | 0.70 | 0.66 | 0.75 | 0.71 | 0.75 | 0.96 | 1,000 |
| Skin irritation/corrosion | 0.72 | 0.77 | 0.66 | 0.69 | 0.74 | 0.94 | 1,012 |
| Eye irritation/corrosion | 0.72 | 0.72 | 0.71 | 0.71 | 0.71 | 0.95 | 3,547 |
| Acute dermal | 0.76 | 0.74 | 0.78 | 0.77 | 0.75 | 0.93 | 2,622 |
| Acute inhalation | 0.74 | 0.69 | 0.80 | 0.77 | 0.72 | 0.95 | 681 |
| Acute oral | 0.77 | 0.85 | 0.70 | 0.79 | 0.78 | 0.95 | 8,442 |
Note: CCR, correct classification rate; NPV, negative predictive value; PPV, positive predictive value; QSAR, quantitative structure–activity relationship; Se, sensitivity; Sp, specificity.
Figure 3.Toxicants identified in the literature using PubMed and Chemotext (see “Data Collection” section in “Materials and Methods” section) that were absent in our modeling data. STopTox predictions for a given end point are listed below each structure’s contribution map, also generated with STopTox.
Figure 4.Maps of fragment contributions and predictions of each model for N-phenyl-p-phenylenediamine. The predicted fragment contribution of a toxic effect is accompanied by the map of the atomic contributions to toxicity. Red regions with continuous lines indicate the fragment is predicted to increase toxicity. Green regions with dashed lines indicate the fragment is predicted to decrease the toxicity.
Indirect comparison of STopTox (5-fold external cross-validation) and RASAR (as reported in the original publication).
| End point | Number of chemicals | CCR | Sensitivity | Specificity | ||||
|---|---|---|---|---|---|---|---|---|
| RASAR* | STopTox | RASAR* | STopTox | RASAR* | STopTox | RASAR* | STopTox | |
| Skin sensitization | 7,670 | 1,000 | 0.88 | 0.7 | 0.8 | 0.73 | 0.96 | 0.68 |
| Skin irritation/corrosion | 46,331 | 1,012 | 0.86 | 0.72 | 0.75 | 0.67 | 0.86 | 0.76 |
| Eye irritation/corrosion | 48,767 | 3,547 | 0.84 | 0.77 | 0.99 | 0.72 | 0.7 | 0.81 |
| Acute dermal | 11,252 | 2,622 | 0.92 | 0.77 | 0.89 | 0.79 | 0.94 | 0.75 |
| Acute inhalation | 11,369 | 681 | 0.91 | 0.76 | 0.9 | 0.72 | 0.91 | 0.79 |
| Acute oral | 32,411 | 8,465 | 0.9 | 0.78 | 0.94 | 0.78 | 0.86 | 0.78 |
Note: CCR, correct classification rate; RASAR, read-across structure–activity relationships. *Data retrieved from (Luechtefeld et al. 2018).